HomeDRMA • NASDAQ
add
Dermata Therapeutics Inc
Previous close
$0.70
Day range
$0.69 - $0.75
Year range
$0.66 - $5.00
Market cap
4.69M USD
Avg Volume
131.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.34M | -26.96% |
Net income | -2.30M | 26.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.72M | 105.32% |
Total assets | 10.01M | 93.16% |
Total liabilities | 2.70M | 97.10% |
Total equity | 7.30M | — |
Shares outstanding | 6.38M | — |
Price to book | 0.58 | — |
Return on assets | -86.41% | — |
Return on capital | -132.01% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.30M | 26.50% |
Cash from operations | -1.93M | 28.49% |
Cash from investing | — | — |
Cash from financing | 8.49M | — |
Net change in cash | 6.56M | 342.48% |
Free cash flow | -607.62K | 61.36% |
About
Founded
2014
Website
Employees
8
